샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787233

세계의 차세대 시퀀스 라이브러리 조제 시장

Next-generation Sequencing Library Preparation
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 220 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 차세대 시퀀스 라이브러리 조제 시장은 2030년까지 41억 달러에 도달

2024년에 19억 달러로 추정되는 세계의 차세대 시퀀스 라이브러리 조제 시장은 2030년에는 41억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 13.4%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 타겟 게놈 시퀀스는 CAGR 10.4%를 기록하며, 분석 기간 종료까지 14억 달러에 달할 것으로 예측됩니다. 전게놈 시퀀스 부문의 성장률은 분석 기간 중 CAGR 15.8%로 추정됩니다.

미국 시장은 5억 350만 달러로 추정, 중국은 CAGR 12.8%로 성장할 것으로 예측

미국의 차세대 시퀀스 라이브러리 조제 시장은 2024년에 5억 350만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 12.8%로, 2030년까지 6억 3,820만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 11.9%와 11.8%로 예측됩니다. 유럽에서는 독일이 CAGR 10.1%로 성장할 것으로 예측됩니다.

세계 차세대 시퀀싱 라이브러리 준비 시장 - 주요 동향 및 촉진요인 정리

차세대 염기서열 라이브러리 준비는 어떻게 유전체 연구를 진행하고 있는가?

차세대 염기서열 분석(NGS) 라이브러리 준비는 유전체 분석에서 중요한 단계이며, 연구자들은 DNA 및 RNA 샘플을 하이스루풋 시퀀싱에 적합한 포맷으로 변환할 수 있습니다. 준비 과정에서 조각화, 어댑터라이제이션, 증폭, 품질관리를 통해 정확하고 효율적인 시퀀싱을 보장합니다. NGS 기술은 유전학에 혁명을 가져왔으며, 정밀의료, 종양학, 감염병 연구, 농업유전체학 등 다양한 분야에서 유전체, 전사체, 후성유전체를 보다 신속하고 비용 효율적으로 분석할 수 있게 되었습니다. 임상 진단에서 NGS의 채택이 증가함에 따라 효율성과 재현성을 높이고, 보다 합리적이고 자동화에 적합하며, 확장 가능한 라이브러리 준비 키트에 대한 수요가 증가하고 있습니다. 또한 단일세포 시퀀싱과 롱 리드 시퀀싱의 발전은 유전체 분석의 한계를 넓혀가고 있으며, 복잡한 시료에 맞는 라이브러리 준비 방법의 개선이 요구되고 있습니다. 연구자들이 시퀀싱의 정확성, 민감도, 처리량 향상을 목표로 하는 가운데, 라이브러리 준비 기술은 계속 진화하고 있으며, 유전체학 분야의 발전에 중요한 역할을 하고 있습니다.

NGS 라이브러리 준비 기술 채택에 영향을 미치는 과제는?

NGS 라이브러리 준비 시장은 변화의 잠재력에도 불구하고 접근성, 효율성, 비용 효율성에 영향을 미치는 몇 가지 과제에 직면해 있습니다. 주요 우려 사항 중 하나는 숙련된 기술자, 고가의 시약, 대규모 시료 취급을 필요로 하는 전통적인 라이브러리 준비 방법의 노동 집약적 특성입니다. 시료 품질과 준비 효율의 편차는 시퀀싱 오류와 데이터 신뢰도 저하로 이어질 수 있으므로 강력한 품질관리 대책이 필요합니다. 또 다른 큰 문제는 라이브러리 준비 키트의 높은 비용으로, 소규모 연구소나 임상 실험실의 경우 엄청난 비용이 소요될 수 있다는 점입니다. 또한 저투입 DNA 및 열화 DNA를 포함한 다양한 시료 유형의 취급이 복잡하므로 고도로 전문화된 프로토콜이 필요하며, 맞춤형 솔루션의 필요성이 증가하고 있습니다. 임상 실험실은 NGS 기반 진단에 대한 엄격한 규정 준수 요건을 준수해야 하므로 규제 문제와 표준화 문제가 임상에서의 채택을 더욱 방해하고 있습니다. 이러한 과제를 극복하기 위해서는 자동화, 시약 화학, 바이오인포매틱스 솔루션의 지속적인 혁신이 필요하며, NGS 라이브러리 준비를 보다 효율적이고, 비용 효율적이며, 다양한 용도에 맞게 확장할 수 있도록 해야 합니다.

기술 혁신은 어떻게 NGS 라이브러리 준비의 미래를 주도하고 있는가?

기술의 발전으로 NGS 라이브러리 준비의 효율성과 정확성이 크게 향상되어 시료 처리 및 시퀀싱 품질에 대한 중요한 문제를 해결하고 있습니다. 가장 영향력 있는 기술 혁신 중 하나는 시료 준비 워크플로우의 자동화, 작업 시간 단축, 인적 오류 최소화, 시료 처리량 향상입니다. 로봇 액체 처리 시스템과 마이크로플루이딕스 플랫폼은 준비 과정을 간소화하고, 임상 및 연구 실험실에서 고처리량 시퀀싱을 보다 쉽게 이용할 수 있도록 돕고 있습니다. 일루미나의 Nextera 기술과 같은 트랜스포자제 기반 라이브러리 준비 방법의 개발은 DNA 단편화 및 어댑터 삽입을 단순화하여 준비 시간과 시약 비용을 절감하고 있습니다. 또한 단일 튜브 및 직접 RNA 시퀀싱 접근법을 통해 복잡한 워크플로우가 필요 없어져 전사체학 연구의 효율성이 향상되었습니다. 분자 바코드와 고유 분자 식별자(UMI)의 발전은 PCR 바이어스를 줄이고 저빈도 변이체를 감지하여 시퀀싱의 정확도를 높이고 있습니다. 바이오인포매틱스에 AI와 머신러닝을 통합하여 최적의 시약 조건을 예측하고 데이터 분석을 개선하여 라이브러리 준비 프로토콜을 최적화하고 있습니다. 이러한 기술 혁신이 계속 진화하면서 NGS 라이브러리 준비 시장은 효율성, 확장성, 임상적 채택을 확대할 수 있는 여건이 조성되고 있습니다.

NGS 라이브러리 준비 시장의 성장을 주도하는 요인은 무엇인가?

차세대 시퀀싱 라이브러리 준비 시장의 성장은 맞춤형 의료에 대한 수요 증가, 질병 연구에서의 NGS 적용 확대, 자동화 및 시약 화학의 기술 발전 등 여러 가지 요인에 의해 이루어지고 있습니다. 종양학, 감염성 질환, 희귀 유전자 질환에서 NGS 기반 진단의 채택이 확대됨에 따라 보다 효율적이고 비용 효율적인 라이브러리 준비 솔루션에 대한 수요가 증가하고 있습니다. 또한 단일세포 시퀀싱의 부상도 시장 성장에 기여하고 있습니다. 연구자들은 개별 세포를 고감도로 분석하기 위해 특수한 라이브러리 준비법이 필요하기 때문입니다. 또한 농업유전체학, 마이크로바이옴 연구, 합성생물학의 확대도 시장 수요를 더욱 촉진하고 있습니다. 이들 분야에서는 유전체 분석에 하이스루풋 시퀀싱이 활용되고 있기 때문입니다. 임상 NGS 용도의 표준화 및 규제 승인 추진도 시장 동향을 형성하고 있으며, 제조업체는 엄격한 진단 요구 사항을 충족하는 컴플라이언스 라이브러리 준비 키트를 개발하고 있습니다. 바이오인포매틱스 및 클라우드 기반 시퀀싱 플랫폼에 대한 투자로 데이터 관리 및 접근성이 향상되어 NGS가 다양한 연구 및 임상 용도에 널리 활용되고 있습니다. 시퀀싱 기술의 발전으로 비용 절감과 정확도가 향상됨에 따라 NGS 라이브러리 준비 시장은 지속적으로 성장하여 유전체 연구와 정밀의료에 혁명을 가져올 것으로 예측됩니다.

부문

시퀀스 유형(타겟 게놈 시퀀스, 전게놈 시퀀스, 전엑솜 시퀀스, 기타 시퀀스 유형), 제품 유형(라이브러리 조제 시약·소모품, 라이브러리 조제 기기), 용도(Drug & Biomarker Discovery 용도, 질병 진단 용도, 암 진단 용도, 생식 의료 진단 용도, 감염증 진단 용도, 기타 질병 진단 용도), 최종 용도(학술·연구기관 최종 용도, 제약·바이오테크놀러지 기업 최종 용도, 병원·클리닉 최종 용도, 기타 최종 용도)

조사 대상 기업의 예

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company(BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.08.18

Global Next-generation Sequencing Library Preparation Market to Reach US$4.1 Billion by 2030

The global market for Next-generation Sequencing Library Preparation estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Targeted Genome Sequencing, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$503.5 Million While China is Forecast to Grow at 12.8% CAGR

The Next-generation Sequencing Library Preparation market in the U.S. is estimated at US$503.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$638.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers Summarized

How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

SCOPE OF STUDY:

The report analyzes the Next-generation Sequencing Library Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies, Inc.
  • Alida Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Claret Bioscience LLC
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Next-generation Sequencing Library Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
    • Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
    • Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
    • Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
    • Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
    • Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
    • Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
    • Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
    • Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
    • Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
    • Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
    • Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
    • Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
    • Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
    • Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
    • Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
    • Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
    • Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
    • Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
    • Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
    • Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
    • Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
    • Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
    • Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
    • Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • JAPAN
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • CHINA
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • EUROPE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • FRANCE
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • GERMANY
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제